• Home
  • About IBT
    • IBT History
    • Management
    • Board of Directors
    • Advisory Board
    • Sustainability Policy
  • Pipeline
    • IBP-9414
    • IBP-1016
    • IBP-1118
    • IBP-1122
  • Families
  • Healthcare Professionals
  • Investors & Media
    • Shares
    • Presentations
    • Share Issue
    • Ownership Structure
    • Corporate Governance
    • Calendar
    • Financial Reports
    • Press Releases
    • Investors & Media Contact
    • Subscribe
  • Contact Us
  • Career
IBT Logo IBT Logo
  • En
  • Sv
  • Home
  • About IBT
    • IBT History
    • Management
    • Board of Directors
    • Advisory Board
    • Sustainability Policy
  • Pipeline
    • IBP-9414
    • IBP-1016
    • IBP-1118
    • IBP-1122
  • Families
  • Healthcare Professionals
  • Investors & Media
    • Shares
    • Presentations
    • Share Issue
    • Ownership Structure
    • Corporate Governance
    • Calendar
    • Financial Reports
    • Press Releases
    • Investors & Media Contact
    • Subscribe
  • Contact Us
  • Career


Thomas J. Schnitzer, M.D., Ph.D.
May 23, 2018

Latest press releases

2023-11-10 08:30 Infant Bacterial Therapeutics AB (publ), Interim report January 1-September 30, 2023 Regulatory
2023-10-24 10:50 Infant Bacterial Therapeutics AB (publ) announces the appointment of the Nomination Committee for the Annual General Meeting 2024 Regulatory
2023-08-25 08:30 Infant Bacterial Therapeutics AB (publ) Interim report January 1 - June 30, 2023
2023-07-31 10:00 New number of shares and votes in IBT Regulatory
2023-07-04 08:30 IBT announces outcome of its rights issue Regulatory
Contact | info@ibtherapeutics.com
© Copyright Infant Bacterial Therapeutics AB 2023
Cookie Policy Privacy Policy Terms of Use